Successful use of the interleukin-17A inhibitor (ixekizumab) in the treatment of psoriatic arthritis
Psoriatic arthritis (PsA) is a chronic immune-mediated disease from a group of spondyloarthritis, which is characterized by damage to the musculoskeletal system with a wide range of different clinical manifestations and is usually associated with psoriasis. Activation of the interleukin (IL) 23/IL17...
Gorde:
| Egile Nagusiak: | , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Russo |
| Argitaratua: |
IMA-PRESS LLC
2020-11-01
|
| Saila: | Современная ревматология |
| Gaiak: | |
| Sarrera elektronikoa: | https://mrj.ima-press.net/mrj/article/view/1085 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|